Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...

A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum ...

Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...

Prenatal genetic testing determines if an offspring is at risk of genetic or hereditary conditions. This can inform the parents of decisions such as keeping the child or not or adjusting to help them ...

Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or inherited diseases. Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or ...

Prenatal genetic tests can detect sex chromosome aberrations, but what happens after—for families and children—is anything but clear. When Ollie’s mother, Katie, was nine weeks pregnant, her ...

Sickle cell anemia is a rare blood disorder passed down in families. Doctors can test for the trait that causes it before, during, or soon after birth. Sickle cell anemia (SCA) is an inherited blood ...